Figure 2. Eyes Completing the 104-Week Visit in the Initial Observation Group.

Injections for “other” category were given for 1 case of proliferative diabetic retinopathy and 1 case of vision loss of 7 letters accompanied by a 150-μm increase in central subfield thickness. Group included 208 of 236 randomized; excluding 4 participants who died during follow-up, 90% of participants completed the 4-year visit.